Physician profile
Athanasios Ssetti Magimbi
NPI 1851470959
$9,774.23
in general payments reported to CMS, 2019-2025
34 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,824 · 2020: $1,253 · 2021: $2,057 · 2022: $1,601 · 2023: $760 · 2024: $1,663 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523 · Travel and Lodging: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.73 |
| Travel and Lodging | $516.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,020.05 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $1,621.86 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $1,416.06 | 2019-2024 | Belbuca |
| Forte Bio-Pharma LLC | $635.91 | 2020-2023 | Prolate, Nalocet |
| Si-Bone, INC. | $588.74 | 2023-2024 | |
| Abbvie INC. | $560.90 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $518.42 | 2019-2022 | |
| Boston Scientific Corporation | $493.47 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $423.70 | 2019-2025 | Proclaim, Eterna |
| Biodelivery Sciences International, INC. | $180.92 | 2019-2020 | |
| Pfizer INC. | $162.67 | 2019-2023 | |
| Horizon Therapeutics Plc | $121.70 | 2019-2022 | |
| Nalu Medical, INC. | $113.14 | 2025 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $95.60 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $79.71 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $74.83 | 2024-2025 | |
| Allergan, INC. | $74.49 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.24 | 2019 | |
| Redhill Biopharma INC. | $56.22 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $54.72 | 2022-2023 | Lyvispah |
| Nevro Corp. | $51.99 | 2021-2024 | Senza |
| Biohaven Pharmaceutical Holding Company Ltd. | $41.50 | 2022 | |
| West Therapeutics Development, LLC | $37.56 | 2019 | |
| Mdd US Operations, LLC | $36.79 | 2019-2020 | |
| Kaleo, INC. | $35.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.09 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $29.89 | 2019-2020 | |
| Almatica Pharma LLC | $29.67 | 2022 | |
| Curonix LLC | $28.77 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $25.30 | 2019 | |
| Daiichi Sankyo INC. | $24.77 | 2019 | |
| Medtronic, INC. | $17.50 | 2021 | |
| Assertio Therapeutics, INC. | $17.15 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Magimbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.